Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,882 | -53,318 | -37,873 | -15,764 | -28,837 |
| Depreciation Amortization | 906 | 636 | 427 | 196 | 860 |
| Income taxes - deferred | 58 | -288 | -21 | 9 | -285 |
| Accounts receivable | -459 | -940 | -608 | -3,238 | -1,032 |
| Other Working Capital | -2,647 | -3,657 | -1,090 | -6,984 | -26,089 |
| Other Operating Activity | 11,522 | 8,775 | 5,380 | 5,073 | 7,259 |
| Operating Cash Flow | $-69,502 | $-48,792 | $-33,785 | $-20,708 | $-48,124 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -244,720 | -29,801 | -45,599 | -54,700 | -14,187 |
| PPE Investments | -2,050 | -1,536 | -1,313 | -404 | -2,637 |
| Investing Cash Flow | $-246,770 | $-31,337 | $-46,912 | $-55,104 | $-16,824 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -16,743 |
| Common Stock Issued | 447,543 | 123,590 | 118,832 | 118,721 | 102,538 |
| Financing Cash Flow | $447,543 | $123,590 | $118,832 | $118,721 | $85,795 |
| Exchange Rate Effect | -592 | -661 | -214 | 67 | -593 |
| Beginning Cash Position | 45,009 | 45,009 | 45,009 | 45,009 | 24,755 |
| End Cash Position | 175,688 | 87,809 | 82,930 | 87,985 | 45,009 |
| Net Cash Flow | $130,679 | $42,800 | $37,921 | $42,976 | $20,254 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,502 | -48,792 | -33,785 | -20,708 | -48,124 |
| Capital Expenditure | -2,050 | -1,536 | -1,313 | -404 | -2,637 |
| Free Cash Flow | -71,552 | -50,328 | -35,098 | -21,112 | -50,761 |